Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST) Meeting Abstract

  

Authors:	de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; Samara, E.; Paz, M.; Tussay-Lindenberg, A.; Wang, K.; Shepherd, S. P.; Kline, I.; Sherman, E.; Rodon, J.
Abstract Title:	Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
Meeting Title:	21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024)
Journal Title:	Neuro-Oncology
Volume:	26
Issue:	Suppl. 4
Meeting Dates:	2024 Jun 28-July 2
Meeting Location:	Philadelphia, PA
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2024-06-01
Language:	English
ACCESSION:	WOS:001252720000501
DOI:	10.1093/neuonc/noae064.155
PROVIDER:	wos
Notes:	Meeting Abstract: TRLS-02 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/219750